Skip to Content
Home
MAb Inventory
About
Contact
Pearl Antigenics, Inc.
Pearl Antigenics, Inc.
0
0
Home
MAb Inventory
About
Contact
Pearl Antigenics, Inc.
Pearl Antigenics, Inc.
0
0
Home
MAb Inventory
About
Contact
MAb Inventory Cytoplasmic Protein (L64, 33-kDa)
GeneralMABHeader.jpg Image 1 of 9
GeneralMABHeader.jpg
Amoeboid Tvag on VEC.jpg Image 2 of 9
Amoeboid Tvag on VEC.jpg
Biofilm Tvag on VEC.jpg Image 3 of 9
Biofilm Tvag on VEC.jpg
Cross Sectioin EM_Dark Tvag on VEC.jpg Image 4 of 9
Cross Sectioin EM_Dark Tvag on VEC.jpg
Illustration of the Vaginal Epithelium.jpg Image 5 of 9
Illustration of the Vaginal Epithelium.jpg
Illustration showing T vaginalis adherent to vaginal epithelial cells.jpg Image 6 of 9
Illustration showing T vaginalis adherent to vaginal epithelial cells.jpg
Pathology PAPsmear of T. vaginalis on VECs of patient.jpg Image 7 of 9
Pathology PAPsmear of T. vaginalis on VECs of patient.jpg
Purified Squamous Vaginal Epithelial Cells with normal flora.jpg Image 8 of 9
Purified Squamous Vaginal Epithelial Cells with normal flora.jpg
Trichomonas vaginalis adherence to HeLa epithelial cells.jpg Image 9 of 9
Trichomonas vaginalis adherence to HeLa epithelial cells.jpg
GeneralMABHeader.jpg
Amoeboid Tvag on VEC.jpg
Biofilm Tvag on VEC.jpg
Cross Sectioin EM_Dark Tvag on VEC.jpg
Illustration of the Vaginal Epithelium.jpg
Illustration showing T vaginalis adherent to vaginal epithelial cells.jpg
Pathology PAPsmear of T. vaginalis on VECs of patient.jpg
Purified Squamous Vaginal Epithelial Cells with normal flora.jpg
Trichomonas vaginalis adherence to HeLa epithelial cells.jpg

Cytoplasmic Protein (L64, 33-kDa)

$0.00

The MAb L64 to a cytoplasmic protein is a control throughout the study of the parasite.

Quantity:
Add To Cart

The MAb L64 to a cytoplasmic protein is a control throughout the study of the parasite.

The MAb L64 to a cytoplasmic protein is a control throughout the study of the parasite.

References for MAb L64


  1. Infect. Immun. 55:1037-1041, 1987. PMCID: 2437029

+1 301-284-8422

© Pearl Antigenics, Inc.